Greenleaf Trust’s Amgen AMGN Stock Holding History

Greenleaf Trust’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.82M	Buy	16,069 +14	+0.1%	+$4.79K	0.06%	99
2026 Q1	$5.65M	Buy	16,055 +973	+6%	+$347K	0.06%	96
2025 Q4	$4.94M	Buy	15,082 +131	+0.9%	+$41.6K	0.05%	105
2025 Q3	$4.22M	Sell	14,951 -1,421	-9%	-$412K	0.04%	115
2025 Q2	$4.57M	Sell	16,372 -1,043	-6%	-$295K	0.04%	111
2025 Q1	$5.43M	Sell	17,415 -179	-1%	-$52.9K	0.05%	99
2024 Q4	$4.59M	Sell	17,594 -143	-0.8%	-$42.4K	0.04%	111
2024 Q3	$5.72M	Sell	17,737 -67	-0.4%	-$21.9K	0.05%	96
2024 Q2	$5.56M	Buy	17,804 +196	+1%	+$57.6K	0.05%	93
2024 Q1	$5.01M	Buy	17,608 +81	+0.5%	+$23.7K	0.05%	101
2023 Q4	$5.05M	Buy	17,527 +7	+0%	+$1.91K	0.05%	96
2023 Q3	$4.71M	Buy	17,520 +1,833	+12%	+$457K	0.05%	90
2023 Q2	$3.48M	Sell	15,687 -1,346	-8%	-$312K	0.04%	109
2023 Q1	$4.12M	Buy	17,033 +666	+4%	+$163K	0.05%	100
2022 Q4	$4.3M	Buy	16,367 +348	+2%	+$93.3K	0.05%	95
2022 Q3	$3.61M	Sell	16,019 -314	-2%	-$76.1K	0.05%	97
2022 Q2	$3.97M	Buy	16,333 +25	+0.2%	+$6.13K	0.06%	84
2022 Q1	$3.94M	Buy	16,308 +3,069	+23%	+$705K	0.05%	83
2021 Q4	$2.98M	Sell	13,239 -2,043	-13%	-$431K	0.03%	99
2021 Q3	$3.25M	Sell	15,282 -26	-0.2%	-$5.98K	0.04%	87
2021 Q2	$3.73M	Buy	15,308 +137	+0.9%	+$33.7K	0.05%	81
2021 Q1	$3.77M	Buy	15,171 +1,691	+13%	+$403K	0.05%	79
2020 Q4	$3.1M	Sell	13,480 -595	-4%	-$137K	0.04%	83
2020 Q3	$3.58M	Sell	14,075 -301	-2%	-$74.6K	0.06%	71
2020 Q2	$3.39M	Buy	14,376 +2,166	+18%	+$494K	0.06%	73
2020 Q1	$2.48M	Buy	12,210 +255	+2%	+$55.7K	0.05%	78
2019 Q4	$2.88M	Sell	11,955 -708	-6%	-$156K	0.05%	83
2019 Q3	$2.45M	Buy	12,663 +2,498	+25%	+$479K	0.04%	87
2019 Q2	$1.87M	Sell	10,165 -2,423	-19%	-$434K	0.03%	102
2019 Q1	$2.39M	Sell	12,588 -806	-6%	-$154K	0.04%	86
2018 Q4	$2.61M	Buy	13,394 +482	+4%	+$94K	0.05%	75
2018 Q3	$2.68M	Buy	12,912 +664	+5%	+$131K	0.05%	80
2018 Q2	$2.26M	Buy	12,248 +976	+9%	+$173K	0.04%	86
2018 Q1	$1.92M	Buy	11,272 +957	+9%	+$176K	0.04%	96
2017 Q4	$1.79M	Sell	10,315 -339	-3%	-$60K	0.04%	107
2017 Q3	$1.99M	Buy	10,654 +1,305	+14%	+$231K	0.04%	94
2017 Q2	$1.61M	Sell	9,349 -666	-7%	-$108K	0.04%	97
2017 Q1	$1.64M	Buy	10,015 +1,737	+21%	+$289K	0.04%	85
2016 Q4	$1.21M	Sell	8,278 -444	-5%	-$66.8K	0.03%	93
2016 Q3	$1.46M	Buy	8,722 +1,303	+18%	+$220K	0.04%	80
2016 Q2	$1.13M	Sell	7,419 -1,167	-14%	-$181K	0.03%	80
2016 Q1	$1.29M	Buy	8,586 +385	+5%	+$57.2K	0.04%	80
2015 Q4	$1.33M	Sell	8,201 -234	-3%	-$36.8K	0.04%	74
2015 Q3	$1.17M	Sell	8,435 -127	-1%	-$20K	0.03%	69
2015 Q2	$1.31M	Buy	8,562 +228	+3%	+$36.5K	0.04%	67
2015 Q1	$1.33M	Sell	8,334 -240	-3%	-$37.8K	0.04%	69
2014 Q4	$1.37M	Hold	8,574	–	–	0.04%	68
2014 Q3	$1.2M	Hold	8,574	–	–	0.04%	68
2014 Q2	$1.01M	Sell	8,574 -168	-2%	-$19.4K	0.03%	82
2014 Q1	$1.08M	Buy	8,742 +6	+0.1%	+$728	0.03%	72
2013 Q4	$997K	Hold	8,736	–	–	0.03%	81
2013 Q3	$978K	Sell	8,736 -288	-3%	-$31.2K	0.04%	77
2013 Q2	$890K	Buy	+9,024	New	+$936K	0.03%	76

Other funds holding AMGN

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

FFM

Forum Financial Management Lombard, Illinois $7.79B AUM 20.38% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

Greenleaf Trust's AMGN Position: Q2 2026 in Review

Greenleaf Trust increased its Amgen (AMGN) stake by 0.09% in Q2 2026, buying an estimated $4.79K and bringing the position to 16,069 shares worth $5.82M. The position accounts for 0.06% of the portfolio, ranked #99.

Greenleaf Trust first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. 1,264 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Greenleaf Trust held 16,069 shares of Amgen worth $5.82M as of Q2 2026.
Greenleaf Trust bought 14 Amgen shares in Q2 2026, an estimated $4.79K.
Amgen made up 0.06% of Greenleaf Trust's portfolio in Q2 2026, its #99 holding.
Greenleaf Trust first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
1,264 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Greenleaf Trust's 13F filing for Q2 2026, filed 21 Jul 2026.